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Women undergoing risk-reducing salpingo-oophorect-
omy through the Prince of Wales Hospital Hereditary
Cancer Clinic are offered enrolment in a prospective
study of bone mineral density (BMD), markers of bone
metabolism and cardio-vascular risk factors. Participants
are invited to enroll a friend who has ovaries in situ and
are aged within five years of the participant as a control
population.
Lumbar spine (LS), femoral neck (FN) and total body
(TB) bone mineral density changes as a percentage
annual loss are reported and compared with age
matched norm. Women who were pre-menopausal at
t h et i m eo fo o p h o r e c t o m yh a v eb e e nc o m p a r e dw i t h
those who were either already post-menopausal at
oophorectomy or had ovaries in situ to evaluate the
impact of this intervention.
59 women have been enrolled and have now had 2 or
more bone density evaluations – 44 cases and 15 con-
trols. 7 women who were taking HRT or drugs affecting
bone metabolism at entry were excluded from this ana-
lysis. The average age of women who had undergone
pre-menopausal RRSO was 48.4yrs and 49.4yrs for the
comparison group.
Of those who were still menstruating at the time of
RRSO and were not taking HRT at enrolment, the aver-
age annual decrease in LS BMD from year 1 to year 2
was 1.3% of enrolment value, in FN was 0.95% and in
TB BMD was 0.6%.The corresponding decrease for the
comparison group was 0.88% in LS, 1.3% in FN and an
increase of 0.26% for TB. Both groups are aged under
50 and demonstrate a greater than average BMD loss
compared with age matched norms (population average
annual LS loss is 0.35% in pre-menopausal women and
0.9% for women in early menopause)[1].
The small cohorts so far do not demonstrate any sta-
tistically significant differences, but recruitment is
ongoing. These findings are consistent with established
data which has shown that LS has the greatest loss of
BMD in the early menopausal years, with stable or even
increasing whole total body BMD
1.
Data will be presented on total body fat and fat distri-
bution changes in these cohorts.
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